Introduction
Progression through the dierent phases of the cell division cycle is controlled by a family of cyclindependent protein kinases. Several types of cyclins have been identi®ed and cyclin A is synthesized at the onset of DNA replication as well as during the G2/M transition (for reviews, see Sardet et al., 1997; Sherr, 1996) . We have previously analysed the expression of cyclin A in primary as well as in human and rodent cell lines (Barlat et al., 1993; 1995; Philips et al., 1998; 1999; Plet et al., 1997) , which led us to delineate functional DNA sequences present in the mouse cyclin A promoter (Barlat et al., 1995; Huet et al., 1996) . In vivo genomic DMS footprinting has revealed the presence of putative protein binding elements within a short region containing the major transcription initiation sites. One of these elements, termed the cell cycle responsive element (CCRE) (Huet et al., 1996; Philips et al., 1998; Plet et al., 1997) or the cell cycle dependent element (CDE) (Zwicker et al., 1995) , is periodically occupied in G0/early G1 when transcription of cyclin A is o. Functional assays where this region directed the expression of a reporter gene, revealed that mutation of the CCRE/CDE resulted in a complete deregulation in G0/G1. This led thus to the notion that a repressor was binding to this element, an observation which was consistent with previous data obtained with human cyclin A promoter (Schulze et al., 1995; Zwicker et al., 1995) . 3' to the CCRE/CDE resides another element mutation of which also abolished cyclin A repression in G0/G1 (Zwicker et al., 1995) . Interestingly, this element, together with the CCRE/CDE was found to be shared by other genes such as B-myb, cdc2 and cdc25C and was therefore termed cell cycle gene homology region (CHR).
Transcription of genes involved in cell cycle control requires coordinate activation and repression of speci®c sets of transcription factors, among which members of the E2F/DP family constitute a thoroughly studied archetype (for reviews, see : Dyson, 1998; Sardet et al., 1997; Weinberg, 1995) . Activity of E2F/DP transcription factors is repressed by their association with pocket proteins of the Rb family. The latter become hyperphosphorylated as cells transit G1 and dissociate from the E2F/DP complex, leading to the activation of E2F-regulated genes. Cyclin A belongs to a group of genes whose transcription is repressed in G0/early G1 and derepressed prior to entry (B-myb, E2F-1) into or during S phase (cyclin A, cdc2), as well as in G2 (cdc25C). These genes are therefore potential target candidates for E2F/DP-mediated repression processes. Whereas E2F-containing complex have been reported to interact with the CCRE/CDE (Liu et al., 1998; Schulze et al., 1995; Zerfass-Thome et al., 1997) no CHR-binding protein has been puri®ed yet. However, an in vitro binding activity termed CDF-1, which is not related to E2F, has been characterized and proposed to interact with both the CDE and the CHR of cdc25C (Liu et al., , 1998 . Electromobility shift assays and oligonucleotide competition experiments suggested the presence of a general factor which was not able to discriminate between the CCRE/CDE-CHR modules of cdc25C, cdc2 and cyclin A. No further characterization of the complex neither the determination of the number and molecular properties of its components were undertaken. The high sequence conservation of the diverse CCRE/CDE-CHR modules together with the apparent lack of speci®city observed in vitro for the binding of CDF-1 are at odds with the observed in vivo sequential timing of promoter activity during the cell cycle. Whereas the dierential binding of E2Fs and CDF could contribute to this timing , our recent data based on speci®c in vitro electrophoretic mobility gel shift conditions prompted us to search for factors speci®c to each CHR.
In the present study, we present evidence that a 90 ± 95 kD polypeptide binds in vitro speci®cally to cyclin A CHR but not to cdc25C or to B-myb, or to cdc2 CHRs. Moreover, we also show that cyclin A and cdc25C CHRs are involved in functionally dierent interactions discriminating their two repressor elements. In vivo microinjection and in vitro transcription experiments using whole cell extracts were carried out in the presence of competing excesses of cyclin A or cdc25C oligonucleotides. When puri®ed plasmids were used as templates in an in vitro transcription assay with whole cell extracts, only a cyclin A oligonucleotide containing an intact CHR was able to relieve cyclin A promoter from inhibitory factors. The inhibitory role of the CHR binding polypeptide was further demonstrated by the use of depleted extracts which were reconstituted with the semi puri®ed CHF activity. Moreover, microinjection in living ®broblasts of cyclin A wild type CCRE-CHR resulted in premature activation of cyclin A gene in late G1 cells, while leaving unaected cdc25C. In contrast, microinjection of oligonucleotides in which the CHR was mutated, was ineective in inducing cyclin A. In addition, microinjection of an oligonucleotide containing cdc25C CDE-CHR did not result in cyclin A premature expression.
Results
Mutations of either the CCRE or the CHR abolish repression of murine cyclin A promoter in G0/G1 primary ®broblasts
The wild type and the various mutated versions of the cyclin A promoter linked to a luciferase reporter (pCycA-luc) were transfected into mouse primary ®broblasts (MEF) which were then serum-starved for 24 h (Philips et al., 1998) . Luciferase activity was monitored 18 h after serum-restimulation. The CCRE-CHR-dependent repression of cyclin A transcription was observed in quiescent cells and was relieved in serum-refed cells as expected (Figure 1 ). However, as previously shown, a constitutive high activity was monitored whether cells were starved in low serum or restimulated when the CCRE-mutated version of the cyclin A promoter was used (Figure 1) , whereas, mutations on the CRE or the NF-Y sites nearby led to promoters only slightly impaired in their response to serum (data not shown) (Huet et al., 1996; Philips et al., 1999) . In contrast, mutation of the sequence immediately 3' to the CCRE, shared by several other cell cycle-regulated genes and termed the`cell cycle gene homology region' (CHR), led to a dramatic upregulation of cyclin A promoter in quiescent cells and which was hardly stimulated by serum (Figure 1) . Mutations on the CHR gave reproducibly rise to a stronger eect than on the CCRE, suggesting that a hierarchy could exist between the two elements. This extends the observations previously made on the human cdc25C, cdc2 and cyclin A promoters (Zwicker et al., 1995) to the murine cyclin A promoter.
The repression of cyclin A transcription in G0/G1 MEF is thus governed by a bipartite cell cycleregulated repressor element consisting of the CCRE/ CDE and a directly adjacent CHR motif.
Binding of factors to cyclin A CHR is cell cycle regulated
Electrophoretic mobility shift assays (EMSA) carried out with total cellular extracts from either MEF, HeLa, Daudi or Kit225 cells suggested the presence of factors harbouring a speci®c interaction with cyclin A CHR. Figure 1 Cyclin A transcription is repressed through a bipartite repressor element. (a) Primary mouse ®broblasts (MEF) were transfected 18 h prior to serum starvation, serum-starved for 24 h, and released from mitogen deprivation by addition of complete medium. Fire¯y luciferase activity driven by the minimal cyclin A promoter, harbouring either a wild type structure (WT) or a mutation in respectively the CCRE (mCCRE), or the CHR (mCHR), is expressed relative to the activity of a co-transfected constitutive Renilla luciferase expression vector. (b) Schematic representation of the cyclin A promoter. ATF, NF-Y and CCRE (Cell Cycle Responsive Element) correspond to previously identi®ed in vivo footprints (Huet et al., 1996) , whereas CHR (Cell cycle gene Homology Region) is the DNA element studied in this work While essentially identical conclusions were reached with all extracts, for practical reasons, the data presented here will deal only with extracts from Kit225 cells. When complex made by such extracts with an oligonucleotide containing the cyclin A CCRE-CHR region, were separated by electrophoresis under non-denaturing conditions, a complex pattern of retarded bands was obtained (Figure 2) . Competition experiments were carried out with non-radioactive oligonucleotides containing mutations which abolish transcriptional repression mediated by either the CCRE or CHR elements. This revealed the presence of three types of complex. The ®rst two were inhibited exclusively by only one type of speci®c oligonucleotide, while unaected by an unrelated oligonucleotide (Figure 2) . Moreover, only one of each complex was obtained when the same type of EMSA was performed with either singly mutated oligonucleotide, while the presence of the two mutations abolished completely any binding (data not shown). Finally, the third type of complex was either reduced by both types of oligonucleotides or left unchanged, and considered as non speci®c. This prompted us to use the oligonucleotide mutated on the CCRE (CHR oligonucleotide) to characterize more precisely the CHR-binding activity.
Extracts were then prepared from cells either cultured for 48 h in the absence of IL-2 (G0) or blocked in S phase using hydroxyl urea (HU). When EMSA were carried out with the CHR oligonucleotide, a prominent retarded complex was observed with extracts from exponential (Exp) or quiescent (G0) cells, which was decreased with extracts from hydroxyl urea-treated cells (HU) (Figure 3a) . The eciency of the synchronization procedures, together with the constancy of protein integrity and concentration in the various extracts were monitored by Western blotting (Figure 3c ). As expected, whereas cyclin A was barely detectable in extracts from IL-2-starved cells (G0), it was abundant in the extract from hydroxyl urea-treated cells (HU). GAPDH remained constant in both instances. Accordingly, an EMSA performed with an oligonucleotide bearing a CAAT binding site showed no variation in complex formation throughout the cell cycle ( Figure 3b) .
The inverse correlation, observed between the binding of factors to cyclin A CHR oligonucleotide and the induction of cyclin A, is consistent with the binding of cell cycle-regulated repressor(s) to cyclin A CHR.
Identi®cation of CHF, a cyclin A CHR-speci®c binding factor
Our previous unpublished observations had suggested the possibility to restore the cyclin A CHR-binding activity after electrophoresis through denaturing polyacrylamide-SDS gels. We therefore took the advantage of the high resolution and capacity of this technique to fractionate a total cellular extract to determine both the size and the number of proteins involved. After electrophoresis, the gel was split into several pieces, and proteins present in each slice eluted, renatured, and submitted to EMSA analysis as described in Materials and methods. A preliminary analytical experiment, where the gel was sliced into Figure 2 Protein complex formed in vitro with the cyclin A CCRE-CHR dual element. Gel shift assays were carried out with a radioactive oligonucleotide containing the cyclin A CCRE-CHR region (see Materials and methods) and a nuclear extract prepared from exponentially growing Kit225 cells. Competition experiments were performed in the presence of a 50-fold molar excess of either wild type (CYC A WT), CCRE mutated (CYC A mutCCRE), or CHR mutated (CYC A mutCHR) unlabelled oligonucleotides. Arrows show speci®c complex involving either the CHR or the CCRE elements. ns stands for non speci®c complex only six dierent regions, suggested a size higher than 60 kD for the factor (data not shown). We subsequently split the region spanning 68 ± 150 kD into 20 slices. Renatured proteins eluted from individual slices were submitted to EMSA analysis, and the result is shown in Figure 4a . A simple pattern with a major retarded complex was formed by proteins present in slices 8 ± 10, corresponding to a 90 ± 95 kD molecular weight. The complex is speci®c since it could be eectively displaced by a 50 molar excess of nonradioactive cognate oligonucleotide whereas it was unaected by a similar excess of the oligonucleotide mutated within the CHR (Figure 4b ).
We next used UV cross-linking experiments to further characterize protein(s) interacting with cyclin A CHR. A BrdU-labelled probe was incubated with cellular extracts in a tenfold scaled up EMSA reaction, and electrophoretic separation of complex carried out as described above, excepting that gels were covered with Saran-Wrap and autoradiographed without drying. The bands corresponding to the protein-DNA complex were sliced out, exposed to a UV lamp and loaded onto polyacrylamide-SDS denaturing gels. After electrophoresis and autoradiography, a single band of approximately 105 ± 110 kD was obtained ( Figure 5 ). Again, the speci®city of the interaction was demonstrated since it was eectively abolished by a 50 molar excess of non-radioactive cognate oligonucleotide whereas unaected by a similar excess of oligonucleotide mutated in the CHR ( Figure 5 ). The eective molecular mass obtained after subtracting the mass of the oligonucleotide is consistent with the 90 kD obtained after polyacrylamide-SDS gel fractionation and renaturation. An identical result was obtained when complex were exposed to UV prior to gel electrophoresis (data not shown).
In conclusion, a 90 ± 95 kD polypeptide, most likely a monomer since the same molecular mass was obtained by gel ®ltration under non denaturing conditions (data not shown), binds speci®cally in vitro to cyclin A CHR, independently of the CCRE. We will subsequently refer to this protein as CHF; cyclin A CHR binding factor. Figure 4 Fractionation of Kit225 whole cell extracts by SDS polyacrylamide gel electrophoresis. (a) 1 mg total proteins prepared from arrested Kit225 cells was loaded onto a preparative 7% polyacrylamide-SDS gel which was then sliced into 2 mm-thick bands spanning the 60 ± 150 Kd MW region. Proteins were eluted, renatured and processed for gel shift analysis with a mutCCRE-CHR cyclin A probe as described in Materials and methods. (b) The speci®city of the complex formed with proteins present in fractions F8 (5 ± 7), F9 (8 ± 10) and F10 (11 ± 13) was assessed by competition with a 50-fold molar excess of either a mutCCRE-CHR (3, 6, 9, 12) or a CCRE-mutCHR (4, 7, 10, 13). For comparison, the same analysis was carried out with the starting whole cell extract (WCE) (2 ± 4). Lane 1 corresponds to probe alone Figure 5 A protein of 90 kD interacts speci®cally with cyclin A CHR as revealed by UV crosslinking. A BrdU-labelled probe was incubated with a cellular extract in a tenfold scaled up EMSA reaction, and separation of the complex by electrophoresis were carried out as described above except that the gel was autoradiographed without drying. Bands corresponding to protein-DNA complex were sliced out, exposed to a UV lamp and then loaded onto a polyacrylamide-SDS denaturing gel (1). The same experiment was performed in the presence of a 50-fold molar excess of either a mutCCRE-CHR (2) or a CCREmutCHR (3) unlabelled probe CHF selectively binds to the cyclin A CHR and not to other CHRs EMSA were performed in the presence of increasing molar excesses of oligonucleotides containing the CCRE-CHR modules of respectively cyclin A, cdc25C, cdc2 and B-myb. Interestingly, whereas an 80% loss of complex formation was observed with 50-fold molar excess of an oligonucleotide containing the wild type cyclin A CHR sequence, a similar excess of oligonucleotides encoding cdc2, cdc25C, or B-myb CHRs only slightly displaced the complex formed with cyclin A CHR (Figure 6) . A 200-fold molar excess of cdc2, cdc25C or B-myb oligonucleotides still left 60 ± 50% of the retarded cyclin A complex unaected, whereas the same excess of cyclin A CHR completely abolished all complex formation. Oligonucleotides containing mutated cyclin A, cdc25C or B-myb CHRs were also without any eect within the 50-fold molar excess range, and gave rise to a 50% reduction in complex formation at a 200-fold molar excess (shown only for cyclin A in Figure 6b ). CHF thus selectively binds in vitro to cyclin A but not to other CHRs.
To address this issue in more functional terms we next developed an in vitro transcription competition assay with whole cell extracts from Kit225 cells. A plasmid, which carries a region of cyclin A promoter spanning nucleotides 7795 to +100 relative to the 3' -most transcription initiation site, was used as a template to generate in vitro transcripts. A plasmid containing adenovirus major late promoter spanning nucleotides 789 to +24 relative to the transcription initiation site (MLP) was added as an internal control. Transcription experiments were performed in the presence of unlabelled triphosphate ribonucleotides, and in vitro-synthesized RNAs were subsequently characterized by RNAse mapping using uniformly labelled antisense RNA probes (see Materials and methods). Competition was carried out using 50-fold molar excess of the same double stranded oligonucleotides as those used for band shift experiments ( Figure  6 ). Whereas essentially the same results were obtained with B-myb, cdc2 or cdc25C oligonucleotides, only results obtained with cyclin A and cdc25C oligonucleotides will be shown from now on. RNAse protection quantitation revealed bands with electrophoretic mobilities as expected for the previously characterized initiation sites (Huet et al., 1996) . Figure 7 focuses only on the major initiation site. Addition of cyclin A wild type oligonucleotide in the transcription assay gave rise to a 2 ± 3-fold increase in transcription eciency, compared to an oligonucleotide with a mutation within the CHR element (Figure 7a, lanes 2 and 3) . However, addition of a cdc25C CHR-containing oligonucleotide did not signi®catively increase transcription of cyclin A promoter relative to the MLP standard (Figure 7a, lane 4) , consistent with the absence of ecient competition observed in the band shift experiments described in Figure 6 . We next tried to con®rm the role of CHF in the repression of cyclin A promoter activity by using an extract depleted in proteins binding to the CHR. Depletion was achieved by exposing the extract to a biotinylated CHR oligonucleotide linked to streptavidin agarose (Materials and methods). Whereas depletion led to a 4 ± 6-fold stimulation of cyclin A promoter activity, reconstitution of the extract after addition of the crude fraction bound to the biotinylated oligonucleotide, restored the inhibition (Figure 7c ± d) . Surprisingly, depleting the extract with the immobilized oligonucleotide was more ecient than just adding it to the transcription assay.
CHF represses selectively cyclin A in vivo
In order to con®rm in vivo, the selectivity observed in vitro we next resorted to oligonucleotide competition experiments using microinjection into living cells. Figure 6 CHF binds in vitro selectively to the cognate element in cyclin A promoter but not to other CHRs. (a) EMSA were performed in the presence of 10 (4, 7, 10, 13), 50 (5, 8, 11, 14) , and 200 (6, 9, 12, 15) molar excesses of oligonucleotides containing the CCRE-CHR modules of respectively cyclin A (4 ± 6), cdc25C (7 ± 9), cdc2 (10 ± 12), and B-myb (13 ± 15). Lane 1 corresponds to probe alone, and lanes 2 and 3 respectively to, no competitor or, a 50-fold excess of CCRE-mutCHR. (b) Quantitative analysis of the gel autoradiographed in (a) The ratio of the radioactivity present in the retarded complex (arrow) to that contained in both the complex and in the free probe was plotted versus the molar excess of each added competitor. The result obtained for a 200-fold excess of mutated cyclin A CHR is shown for comparison Double stranded oligonucleotides containing the CCRE and CHR elements of cyclin A and cdc25C were used with either the wild type sequence or with a mutated CHR element. We have previously shown that in HS68 human primary cells synchronized by serum deprivation, S phase initiated synchronously at 17 h after refeeding. Prior to S phase, HS68 cells are devoid of cyclin A (Girard et al., 1991) and cdc25C expression occurs throughout the cell cycle, but undergoes a strong stimulation 12 h after refeeding and a second peak during G2 (Turowski, Fernandez and Lamb, manuscript submitted). We therefore investigated whether these dierent oligonucleotides were equally eective in inducing cyclin A or cdc25C expression. For each experiment, oligonucleotides were diluted into injection buer containing inert mouse antibodies for subsequent identi®cation of injected cells. Cells were microinjected indierently into the cytoplasm or the nucleus. As shown in Figure 8d , microinjection of the wild type cyclin A CCRE-CHR into G1 cells was sucient to alleviate the transcriptional block to cyclin A expression. Indeed, all three microinjected cells (marked by arrows) induced cyclin A protein expression to a detectable level. In contrast, microinjection of an oligonucleotide with a mutation of the CHR element was poorly eective in inducing cyclin A expression in cells at the same point in the cell cycle as shown in the right hand panel of Figure 8b . However, cdc25C accumulation was not aected by the microinjection of cyclin A oligonucleotides (Figure 9 ). We next examined if the cdc25C CDE-CHR oligonucleotide could eectively relieve the inhibition of cyclin A expression. As shown in Figure 8f , microinjection of the cdc25C oligonucleotide was insucient to induce cyclin A expression. Of the four cells shown in the ®eld, none shows eective cyclin A induction. For each oligonucleotide three independent sets of microinjection experiments were carried out with clear and reproducible outcomes for cyclin A expression. Wild type cyclin A oligonucleotide gave rise to respectively 17/22, 12/15, and 8/11 positive cells; mutated cyclin A oligonucleotide to 0/20, 0/16, 1/28; wild type cdc25C oligonucleotide: 2/18, 0/15, 1/25. Taken together our results show that 77% of cells (n=48) injected with cyclin A CCRE-CHR expressed cyclin A and none harboured a detectable increase in cdc25C. In contrast, injection with cdc25C CDE-CHR had almost no eect on cyclin A accumulation (5% of 58 injected cells expressed some nuclear cyclin A). In all cases the expression fell to only 1% (n=64) when using an 
Discussion
Cyclin A expression at the onset of DNA synthesis results essentially from a transcriptional derepression of its gene. This is caused by the removal of an inhibitory complex present on the promoter, which has been demonstrated by both in vivo genomic footprinting and in vitro mutagenesis (Huet et al., 1996; Schulze et al., 1995; Zwicker et al., 1995) . The region responsible for repression has been identi®ed: CDE (for cell cycle dependent element), or CCRE (for cell cycle responsive element), leading to the proposal that the molecular basis of the periodic transcription of cyclin A is due to the cyclic association and dissociation of a repressor complex. Close examination of cyclin A promoter has led to the identi®cation of a second region, which contains sequences found in several other cell cycle regulated genes and suggesting a common regulatory factor (Zwicker and MuÈ ller, 1998) . The CDE motif, with sequence similarity to an E2F binding site, is thus followed by a region common to cdc25C, B-myb, cdc2, and cyclin A, and therefore termed cell cycle genes homology region (CHR). DMS protection Figure 8 Microinjection in mid-G1 cells of cyclin A CCRE-CHR oligonucleotide, but not that of cdc25C, induces premature cyclin A expression. Cells were synchronized by serum starvation and then, restimulated into G1 for 6 h and microinjected with either a CHR-mutated (a, b), or a wild type (c, d) cyclin A CCRE-CHR oligonucleotide. Cells were also injected with a wild type Cdc25C CDE-CHR oligonucleotide (e, f). Two to four hours after injection, cells were ®xed and stained for cyclin A (b, d, f) as well as for the presence of an inert marker antibody included in the injection solution (a, c, e). Shown are representative¯uorescent micrographs of cells injected with both oligonucleotides and stained for both antibodies. Arrows point to microinjected cells. Bar=10 mm clearly demonstrates the presence of contacts in the major DNA groove for the CDE/CCRE, with the possibility of contacts also in the minor groove of the CHR (Huet et al., 1996; Liu et al., 1996 Liu et al., , 1997 Zwicker et al., 1995) . Mutation of either motifs results in derepression of cyclin A promoter, with however a much stronger eect of a mutation on the CHR than on the CCRE, implying the existence of a dual repressor element. The CCRE/CDE-CHR bipartite repressor could either comprise two contiguous, independent protein binding sites, or two exclusive protein binding sites, or as well, a single binding site for a protein with two cooperative contacts with DNA.
As already mentioned, the CCRE resembles a variant E2F site (Schulze et al., 1995) , and overexpression of E2F-1 was shown to upregulate cyclin A (DeGregoris et al., 1995; Schulze et al., 1995) . However, in vitro gel shift experiments have shown that recombinant E2F members harbour a very low anity for cyclin A CCRE element (Huet et al., 1996; Liu et al., 1997) . Such a discrepancy could be resolved taking into account the in¯uence of chromatin and of neighbouring sequences. Indeed, we had shown in a previous work that the CCRE-CHR element was not sucient to endow an enhancer-less promoter with cell cycle-dependent repression (Huet et al., 1996) . Moreover, we had proposed that the NF-Y factor could Figure 9 Microinjection in mid-G1 cells of cyclin A CCRE-CHR oligonucleotide has no eect on cdc25C expression. Cells were microinjected with either a CHR-mutated (b, d, f), or a wild type (a, c, e) cyclin A CCRE-CHR oligonucleotide. Cells were processed essentially as described in the legend of Figure 8 . Cells were ®xed and stained in the presence of an inert marker antibody included in the injection solution (a, b), for cdc25C (c, d), as well as for DNA with Hoechst stain (e, f). Bar=10 mm organize the binding of the nearby factors, leading thus to a stabilization of otherwise weak interactions (Plet et al., 1997) . Nevertheless, mutations of the cyclin A CCRE which altered E2F binding did not aect repression . In the same report, only E2F-1 and E2F-3 were shown to interact at the expense of E2F-4, which is the only member detectable in G0-early G1 extracts, thus questioning a role for E2F in repression of cyclin A. On the other hand, CHR has clearly been involved in repression, and its selectivity was suggested by experiments exchanging cdc25C CHR for the CHR of B-myb eectively abolishing cdc25C repression (Liu et al., 1996) .
In order to understand how CHR participates in cyclin A downregulation, we have undertaken the characterization of cyclin A CHR binding activity. In the present study we show that binding to the CHR can occur in the presence of mutations within the CCRE element. The existence of a DNA-protein complex on the CHR seems to preclude binding to the CCRE, since only complex corresponding to each individual element were visible by gel mobility shift assays. This could either be due to the binding of mutually exclusive complex, or to the existence of hetero oligomers with decreased anity for the dual element. The capacity to renature the cyclin A CHRbinding activity after electrophoresis through denaturing polyacrylamide-SDS gels led to the identi®cation of a 90 kD protein. This size estimation was con®rmed after UV crosslinking to a radioactive oligonucleotide in a standard band shift experiment.
The interaction of the 90 kD protein was selective since B-myb, cdc2 and cdc25C CCRE/CDE-CHR dual elements were not able to interfere with the binding to the corresponding cyclin A structure. Moreover, this selectivity was also re¯ected at the functional level by both in vitro and in vivo titration assays. Addition of a cyclin A CCRE-CHR oligonucleotide to an in vitro transcription assay, resulted in an increase of cyclin A promoter transcription in the presence of a whole cell extract. This partial relief of a transcriptional block was not observed with a cdc25C CDE-CHR. Moreover, this eect was completely abolished by a mutation within the CHR sequence. We therefore investigated whether these dierent oligonucleotides were equally eective in inducing cyclin A expression in vivo through microinjection experiments in living cells. Whereas cyclin A oligonucleotide was able to give rise to a premature expression of cyclin A in Mid-G1, cdc25C oligonucleotide failed to do so.
Taken together these data suggest that the 90 kD polypeptide is instrumental in establishing a cell cycleregulated repression of cyclin A transcription. The absence of reactivity of the 90 kD polypeptide with many antibodies allowed us to rule out the possibility that it corresponds to a previously described protein (data not shown). At the moment, many questions are still open. First of all, we do not know whether cell cycle-regulated genes such as cdc2, cyclin A, B-myb or cdc25C, which contain similar DNA regulatory elements, are under the control of a common or a family of factors. In the latter case, CHF would belong to a family of factors each endowed with a speci®city towards a selected subset of genes. Alternatively, CHF selectivity could be aected either by the binding of additional cofactors or by post-translational modifications, which would redirect it to other promoters. The mechanism of inhibition itself is still ill-de®ned. Cyclin A promoter is devoid of a TATA element and as such, gives rise to many transcription initiation sites. Interestingly, CHF binds downstream from the major initiation sites and could thus interfere with RNA polymerase progression, leading for example to transcriptional pausing. Whereas the involvement of transcriptional pausing in cell cycle regulation of cyclin A has not been investigated yet, preliminary results suggest that this might be a possibility which should be explored further. The use of KMnO 4 , which preferentially reacts with pyrimidines in single stranded regions, points to the presence of clustered hypersensitive regions, a hallmark of paused RNA polymerases, downstream from cdc25 transcription initiation sites . Alternatively again, CHF would function through the interaction of a cofactor, attracting for example a corepressor which would interact with either the basal transcription machinery, or the surrounding chromatin. Along this line, several reports have previously shown that cyclin A is deregulated in Rb(7/7) ®broblasts (Herrera et al., 1996; Knudsen et al., 1998; Philips et al., 1998 Philips et al., , 1999 . Whereas Rb does not directly contact DNA, it is known to interact with transcription factors such as E2F (Dyson, 1998; Sardet et al., 1997; Weinberg, 1995) , repressing transcription by masking their transactivation domain. More recently, Rb has also been shown to physically interact with the histone deacetylase HDAC1 (Magnaghi-Jaulin et al., 1998) which thus cooperates with it in silencing downstream elements. Should CHF function the same way, either directly or in conjunction with Rb, this would designate it as a new regulatory element of chromatin structure. Understanding how cyclin A downregulation is actually achieved at the molecular level thus requires the isolation of CHF's cognate cDNA.
Materials and methods

Cell culture, cellular extracts and transient transfections
Interleukin-2 (IL2)-dependent human T lymphocytic cell line Kit225 was grown in RPMI 1650 supplemented with 10% foetal calf serum, 2 mM L-glutamine and 1 nM recombinant IL-2 (Plet et al., 1997) . Early primary mouse (MEF) or human ®broblasts (HS68) were obtained from the European cell and tissue culture collection and grown in DMEM containing 10% heat inactivated foetal calf serum without antibiotics. Kit225 cells were arrested by a 48 h IL-2 starvation or grown exponentially. Their state was monitored through¯uorescent cell sorting analysis. Prior to lysis, cells were washed with cold PBS and then centrifuged for 5 min at 1500 g. Pelleted cells were lysed by freeze ± thawing twice in 20 mM HEPES pH 7.8, 2 mM 1 ± 4 dithiothreitol (DTT), 20% (v/v) glycerol, 400 mM NaCl, 1 mM EDTA, 0.5 mM aprotinine and leupeptine. Cellular debris were spun down for 10 min at 10 000 g and the cleared supernatant was stored at 7808C after protein concentration determination. MEF were transfected using the calcium phosphate procedure 18 h prior to serum starvation, serum-starved for 24 h, and then released from mitogen deprivation by addition of complete medium. Fire¯y luciferase activity was monitored on duplicates, 18 h later as previously described (Barlat et al., 1995; Huet et al., 1996; Philips et al., 1998) and normalized to a constitutive Renilla luciferase expression vector (pRL-TK). 5 mg total DNA was used for 10 5 cells per 3.5 cm diameter petri dishes (0.5 mg pCycA-luc, or the various mutants as indicated, 0.1 mg pRL-TK, expression vector as indicated in each ®gure legend and pBluescript SKII + qsp 5 mg).
Gel mobility shifts and UV crosslinking The following double stranded oligonucleotides were used: cyclin A CCRE-CHR: 5'-CCTAGATAGTCGCGGGCTACTTGA-ACTACA; mCCRE-CHR: 5'-CCTAGATAGTCTAATGC-TTGAACTACA; CCRE-mCHR: 5'-CCTAGATAGTCG-CGGGCTACTGTCCCTACA; cdc25C CdE-CHR: 5'-GC-TGGCGGAAGGTTTGAATG; cdc2 CDE-CHR: 5'-TA-GCGCGGTGAGTTTGAAAC; B-myb CDE-CHR: 5'-CT-TGGCGGGAGATAGGAAAG; CAAT box: 5'-AGT-GAACCAATCAGAGCCCCA. Annealed oligonucleotides were labelled with the Klenow fragment of E. coli DNA polymerase I in the presence of 120 mM each of dATP, dGTP, dTTP and 1.85 MBq [a 32 P]dCTP (111 TBq/mMole, Amersham), and recovered by gel ®ltration through sephadex G25 (Pharmacia) mini columns.
For gel shift experiments, 16 mg proteins were incubated for 20 min at 258C in a total volume of 20 ml of 20 mM HEPES pH 7.8, 20 mM MgCl 2 , 2% (W/V) ®coll, 5% (v/v) glycerol, 300 ng poly(dI-dC) and 20 fMoles radioactive probe, together with the indicated molar excess of competitor oligonucleotide. Complexes were separated by electrophoresis at 10 V/cm for 2 h through polyacrylamide gels (acrylamide:bis-acrylamide 29 : 1) run in 0.56TBE. Gels were dried and submitted to autoradiography.
For UV crosslinking experiments, the lower strand cyclin A CCRE-CHR oligonucleotide was annealed to the 12 mer: 5'-ATAGTCGCGGGC and transcribed with Klenow fragment in the presence of 100 mM Br-2-dUTP, dGTP and dATP, and 1 MBq [a 32 P]dCTP (111 TBq/mMole, Amersham). Interaction of the probe with cellular extracts in a tenfold scaled up experiment and separation of the complex by electrophoresis were carried out as described above except that the gel was covered with Saran-Wrap and autoradiographed without drying. The bands corresponding to the protein-DNA complex were sliced out and exposed for 5 min at 20 cm of a UV lamp (100 mJ:cm 2 ). Slices were then boiled for 5 min in Laemmli buer and loaded onto a 7% polyacrylamide-SDS denaturing gel, which was dried after electrophoresis and exposed for autoradiography.
Protein fractionation, denaturation and renaturation 1 mg total proteins prepared from arrested Kit225 cells was loaded onto a preparative 7% polyacrylamide-SDS gel and run for 2 h at 10 V/cm. The gel was sliced into 2 mm-thick bands spanning the 60 ± 150 Kd MW region which were then incubated for 3 h at 378C in two volumes of buer A (150 mM NaCl, 20 mM HEPES pH 7.5, 5 mM DTT, 0.1 mM EDTA, 0.1 mg/ml bovine serum albumin (BSA), 0.1% SDS). Gel debris were eliminated by passing the sample through a spun-down spin X column and proteins were precipitated with four volumes of acetone. The dried pellet was resuspended into 6 M guanidinium chloride in buer A for 20 min at room temperature, and then dialyzed for 16 h at 48C against 500 ml buer A containing 1 mM PMSF. Samples were stored at 7808C.
Cell-free transcription and characterization of the in vitro-produced transcripts by RNAse protection assay Transcription experiments were performed at 308C for 60 min in the presence of 500 mM unlabelled ribonucleotide triphosphates, 5 mg whole cell extract, 1 mg of pCycA-luc and 0.1 mg pMLP supercoiled plasmids, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES; pH 7.9), 8 mM MgCl 2 , 50 mM KCl, 0.5 mM phenylmethylsulphonyl¯uoride, 0.5 mM dithiothreitol, 12.5% (v/v) glycerol, 0.2 mM EDTA, 2 mM creatine phosphate, in a ®nal volume of 30 ml. When indicated, a 50-fold molar excess of the double stranded oligonucleotides used for gel shift experiments, and corresponding to either cyclin A or cdc25C sequences, were added in the assay. CHF depletion was achieved after ®ve passages of a ®vefold diluted extract in the buer used for band shift assays, onto a biotinylated cyclin A CHR oligonucleotide linked to streptavidin agarose (60 nmoles oligonucleotide/ml packed resin). CHR-binding activity was recovered by elution with 1 M NaCl in binding buer containing 1 mg/ml BSA. RNA products were puri®ed by organic extraction and analysed in an RNAse protection assay with antisense RNA probes covering cyclin A and MLP promoter regions (Huet et al., 1996) . Protected fragments were run through 5% polyacrylamide-8M urea sequencing gels, and cyclin A signals were standardized to MLP signals using a Phosphorimager.
Microinjection Human HS68 primary ®broblasts (passage 12) were seeded onto acid washed coverslips and synchronized essentially as described previously (Barlat et al., 1995; Girard et al., 1991) . After a 36 h period of serum starvation, growth was stimulated by the addition of fresh media containing serum, and cells were microinjected 3 ± 6 h thereafter. Cells were allowed to express proteins 2 ± 6 h prior to ®xation in 3.7% formaldehyde in PBS. Cyclin A, cdc25C and inert marker IgG rabbit antibodies (Sigma) included in the injection solution were detected by immuno¯uorescence using anti cyclin A (1/500) or anti cdc25C (1/100, Santa-Cruz Biotechnologies) anity-puri®ed antibodies in PBS-BSA. Cell nuclei were stained with Hoechst 33342. Images were aquired on a Leica DMRB microscope using either a Kodak DCS 420 or DCS420B camera, transferred to a SGI Onyx and mounted under Showcase 3.3.
